BOYS,MARK LAURENCE,RIZZI,JAMES P.,RODRIGUEZ,MARTHA E.,TOPALOV,GEORGE T.,ZHAO,QIAN,BRADLEY,MICHAEL,DELISLE, ROBERT KIRK,HENNINGS,D.DAVID,KENNEDY,APRIL L.,MARMSATER,FREDRIK P.,MEDINA,MATTHEW,MUNSON,MARK
申请号：
MYPI 2012002855
公开号：
MY163791A
申请日:
2010.12.20
申请国别(地区):
MY
年份:
2017
代理人:
摘要：
COMPOUNDS OF FORMULA I: AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF IN WHICH R¹, R², R³, R⁴ AND R⁵ HAVE THE MEANINGS GIVEN IN THE SPECIFICATION, ARE INHIBITORS OF cFMS AND ARE USEFUL IN THE TREATMENT OF BONE-RELATED DISEASES, CANCER, AUTOIMMUNE DISORDERS, INFLAMMATORY DISEASES, CARDIOVASCULAR DISEASES AND PAIN.
